RenovoRx RNXT
NASDAQ RNXT
$1.28 -0.04 (-2.65%)
As of: Aug 21, 2026 · 10:20 AM EDT

RenovoRx (RNXT) Net Margin (QoQ) (2025 - 2026)

RenovoRx (RNXT) Net Margin (QoQ) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 140.39 Bn 132.54 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.47 Bn 78.47 Bn 3.93 Bn
3 Argenx Se 65.25 Bn 60.07 Bn 1.37 Bn
4 Moderna 61.79 Bn 56.66 Bn 52.00 Mn
5 BeOne Medicines 42.27 Bn 37.17 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.17 Bn 27.86 Bn 992.69 Mn
7 BioNTech SE 28.61 Bn 10.22 Bn 668.28 Mn
8 Insmed 27.44 Bn 26.28 Bn 358.27 Mn
9 Royalty Pharma 27.30 Bn 26.46 Bn -
10 RenovoRx 59.87 Mn 59.87 Mn 766,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 23,633.00
Mar 31, 2026 86,140.00
Dec 31, 2025 4,682.00
Sep 30, 2025 -65,773.00
Jun 30, 2025 86,962.00